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Available online 12 January 2016AbstractPurpose: To compare long term efficacy of phacoemulsification in the early management of acute primary angle closure (APAC) after aborting
an acute attack and performing laser peripheral iridotomy (LPI).
Methods: In this nonrandomized comparative prospective study, we included 35 subjects presenting with APAC who had responded to medical
treatment and LPI with intraocular pressure (IOP) less than 25 mmHg. Twenty patients with visually significant cataract with visual acuity of
<20/30 were assigned to the “Phaco/LPI” group and underwent phacoemulsification within 6 weeks of the attack. Fifteen subjects with clear
lens were assigned to the “LPI Only” group and were followed clinically. The primary measured outcome was the prevalence of IOP rise after 1
month (treatment failure), defined as 1) if a patient developed IOP rise resulting in IOP >21 mmHg with or without medication, or 2) if a patient
required any medication to have IOP 21 mmHg after 1 month. Patients were followed for at least one year.
Result: IOP, number of medications, gonioscopy grading, and amount of synechiae were not significantly different at baseline between the two
groups. Acute attack did not recur in any patient. There was more significant failure in the LPI Only group compared with the Phaco/LPI group
(40% vs. 5%; p ¼ 0.02). There was a significant difference in final IOP between the two study groups (13.90 ± 2.17 vs. 17.8 ± 4.16 in the Phaco/
LPI and LPI Only groups, respectively; p ¼ 0.001). Patients in the Phaco-LPI group needed less medication than the other group at final follow-
up. No serious complications have arisen from the immediate LPI or phacoemulsification.
Conclusion: Phacoemulsification is a safe procedure for preventing IOP rise after aborting acute primary angle closure if performed within a few
weeks of the attack.
Copyright © 2015, Iranian Society of Ophthalmology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).of glaucoma blindness.1 Early detection of PACG can prevent
morbidity in a large proportion of affected patients, and early
treatment can minimize any damage to the anterior chamber
angle and optic nerve.2
Acute primary angle closure (APAC) is a subgroup of angle
closure disease characterized by sudden intraocular pressure
(IOP) rise and its consequences, such as headache, corneal
edema, reduced vision, seeing halos around lights, mid-dilated
and sluggish pupil, eye pain, and redness.3e6 An ophthalmo-
logic emergency, its treatment has two arms: IOP reduction and
relief of angle closure. Although laser peripheral iridotomy
(LPI) can relieve angle closure, open the angle, and preventosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND
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not completely prevent chronic angle changes, and up to 60% of
LPI-treated patients eventually develop chronic IOP rise.1,3,4,6,7
A lens-induced mechanism in the development of APAC
has been suggested. A thick crystalline lens might lead to
angle closure through reduction of anterior chamber depth and
narrowing of the angle.8e10
Previous studies have reported IOP control and angle
opening after phacoemulsification in PACG.11e15 Phaco-
emulsification has been shown to be effective in refractory
cases of acute angle closure as well as in eyes with
controlled attacks.6,16e18 Roberts et al successfully treated
APAC patients who did not respond to LPI with phaco-
emulsification.18 In a randomized clinical trial, Lam et al6
showed that early phacoemulsification might be more
effective than LPI in preventing IOP rise in APAC eyes after
aborting an attack. They recommended that it would be
optimal to have the surgery done after the eye has become
quiet to reduce intraoperative complications and post-
operative inflammation.
The aim of this nonrandomized interventional cohort study
in an Iranian population is to evaluate the effect of early
phacoemulsification on long-term IOP control after successful
control of attack with medications and LPI.
Methods
In this nonrandomized interventional prospective study, the
study population consisted of 40 eyes of 40 Iranian patients
with APAC attacks. Patients were seen at the glaucoma clinic
and emergency ward of Farabi Eye Hospital between April
2008 and March 2012.
Written informed consent was obtained from all partici-
pants. Approval was obtained from the institutional review
board Farabi Eye Hospital. The study was carried out in
accordance with the tenets of the Declaration of Helsinki.
Acute primary angle closure was defined as: (1) having at
least 2 of these symptoms: ocular or periocular pain, nausea
and/or vomiting, and intermittent vision blurring; (2) intra-
ocular pressure of more than 25 mmHg measured by Gold-
mann applanation tonometry in conjunction with at least three
of these signs: corneal epithelial edema, conjunctival injection,
non-reactive mid-dilated pupil, and shallow anterior chamber;
and (3) presence of an occluded angle in the affected eye that
is proven by gonioscopy. Occludable angle closure was
defined if the posterior trabecular meshwork could not be
visualized in at least 3 quadrants.
The inclusion criteria were: (1) uncontrolled IOP (IOP
>25 mmHg) caused by APAC; (2) age of at least 18 years; and
(3) ability to give informed consent and cooperate for the YAG
laser procedure. Exclusion criteria were: (1) previous history
of intraocular surgery or trauma; (2) glaucomatous optic
neuropathy in the affected eye; (3) any other treatments for the
acute attack received before enrollment in the study; (4)
corneal opacity in the peripheral iris preventing laser access;
and (5) other ocular disorders that may affect function or
structure of the angle.The acute primary angle closure attack was managed with a
fixed protocol initially. First we administered intravenous
mannitol followed by oral acetazolamide (1 g/day), topical
timolol two times per day (BID), pilocarpine four times per
day (QID), and corticosteroid (QID). The IOP was measured
at 2 h and at 1 day after the starting attack. The attack was
considered broken when IOP was less than 25 mmHg (with or
without medication) and when signs and symptoms of acute
IOP rise had subsided. Once IOP was reduced medically, all
subjects were assessed for eligibility for the study.LPIAll the patients underwent LPI. After administering 2%
pilocarpine, laser treatment was started with a single 5-mJ pulse
(Nd:YAG laser), and the power was increased until a 200 mm
patent opening was achieved. Patency of the LPI was deter-
mined by visualization of fluid flush coming out of the opening
and by LPI size using the 0.2 scale of the slit lamp beam scale.
A single glaucoma specialist (S.M.) performed all laser pro-
cedures. All the patients received topical timolol (BID) and
corticosteroid (QID) for 1 week postoperatively. Additional
glaucoma medications were added to the regimen if necessary.GroupingAfter excluding the patients whose IOP was higher than
25 mmHg within 10 days after medical (more than 3 medica-
tions) and laser treatment, the patients classified into “visually
significant cataract” group (Phaco/LPI Group) and “clear lens”
group (LPI Only Group). Significant cataract was defined as
best corrected visual acuity (BCVA) <20/30 that can be
attributed to lens opacity. Patients in the Phaco/LPI Group
underwent early cataract surgery within 6 weeks of the attack.
Cataract extraction was performed under topical anesthesia
using a standardized temporal clear corneal approach. We
placed intraocular lenses in the capsular bag in all eyes. All
operations were performed by a one surgeon (S.M.). Patients in
the LPI Only Group were followed in the clinic.Follow-up and examinationSlit-lamp examination of the anterior segment, Goldmann
applanation tonometry, and gonioscopy (with and without
indentation) using a Zeiss-style 4-mirror goniolens (Model G-
4; Volk Optical, Mentor, Ohio, USA) were conducted before
LPI and 10 days after LPI. The Shaffer grading system was
used to evaluate the angle on gonioscopy. Peripheral anterior
synechiae (PAS) were defined as abnormal adhesions of the
iris to the angle to the level of the trabecular meshwork which
are at least 15 in width, and could not be broken with
indentation gonioscopy. The extent of PAS was noted in de-
grees. The data from the exam performed at 10 days after LPI
was considered as baseline for comparison with exam findings
at the final follow-up.
After treatment, both groups were followed at day 1; day 7;
day 10; months 1, 3, 6, 9, and 12; and every 6 months thereafter.
Fig. 1. Patient flow from presentation to study exit. IOP ¼ intraocular pressure
(mmHg).
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a minimum follow-up period of 1 year. At each visit, BCVA,
IOP, gonioscopy, peripheral anterior synechiae (PAS) extent, and
medical therapy were recorded. Visual field was evaluated by
24-2 Swedish Interactive Thresholding Algorithm (SITA-Stan-
dard) strategy (Humphrey Field Analyzer, HFA II; Carl Zeiss
Meditec, Inc., Dublin, CA) every 6 months. The visual field was
defined as reliable when fixation loss was <33% and the false
positive and false negative error rates were <20%. Intraocular
pressure greater than 21 mmHg with or without medication after
1 month was defined as treatment failure in this study.
During follow-up, if IOP was more than 21 mmHg or if the
patient experienced repeated visual field progression, topical
glaucoma medications were initiated to maintain
IOP21 mmHg. We administered glaucoma medications in
the following order: beta-blockers, prostaglandin analogs,
carbonic anhydrase inhibitors, and adrenergic agonists. The
primary measured outcome was the prevalence of IOP rise
(treatment failure), which was defined as 1) if a patient
developed IOP rise resulting in IOP>21 mmHg with or
without medication, or 2) if a patient required any medication
to have IOP 21 mmHg after 1 month.StatisticsStatistical analyses were performed using SPSS for Win-
dows (version 18.0, SPSS, Inc., Chicago, IL). The mean and
SD were calculated for the continuous variables. Categorical
variables were expressed as individual counts and proportions.
Univariate analyses were performed using the ManneWhitney
U test for continuous variables and chi-square test for cate-
gorical data. Preoperative and postoperative data were
compared using the Wilcoxon signed-rank test. A p-value less
than 0.05 was considered to be statistically significant.Results
Forty eyes of 40 patients with acute PACG were recruited
into the study. Before LPI, gonioscopy revealed completely
closed angles or poorly visible angles due to corneal edema.
After LPI, the mean Shaffer gonioscopy grading increased fromTable 1




Onset of self-reported symptom to consultation (days)
Maximum IOP at presentation (mmHg)
Time between abortion of attack and LPI (days)
Time between abortion of attack and phacoemulsification (days)
Mean shaffer gonioscopy grading before LPI
Vertical cup-to-disc ratio
Mean deviation (dB) 1 months after procedure
Axial length (mm)
IOP: intraocular pressure; LPI: laser peripheral iridotomy.0.25 ± 0.29 to 1.35 ± 0.78 ( p ¼ 0.001). Of the 40 eyes, 5 were
excluded because IOP control could not be achieved with
medications after LPI. Three of these 5 patients underwent
phacoemulsification, and the other 2 underwent combined
phacotrabeculectomy procedure. Among the final study sample,
20 patients had significant cataract and underwent phacoemul-
sification (Phaco/LPI group). The remaining 15 patients un-
derwent no procedures after LPI (LPI Only group) (Fig. 1). LPI
was performed in all patients within 5 days of presentation. All
the subjects in the Phaco/LPI group underwent phacoemulsifi-
cation within 6 weeks of the attack with a mean of 23.6 ± 9.2
(range: 12 to 42) days. No serious complications have arisen
from the immediate LPI or phacoemulsification.
The demographic and clinical characteristics of the two
treatment groups are presented in Table 1. The majority of
patients were female (15 out of 20 in the Phaco/LPI group
and 12 out of 15 in the LPI Only group), with the mean age
of 61.1 ± 6.9 (range: 52 to 74) years in the Phaco/LPI groupstudy and assigned in the Phaco-LPI group and the LPI only group.
Phaco-LPI group LPI only group p values
20 15
61.1 ± 6.9 60.0 ± 8.9 0.61
15/5 12/3 0.73
4.6 ± 4.7 5.1 ± 4.8 0.56
54.0 ± 9.4 57.1 ± 10.2 0.45
2.1 ± 1.6 1.7 ± 1.5 0.16
23.6 ± 9.2 e e
0.27 ± 0.29 0.21 ± 0.30 0.52
0.32 ± 0.17 0.35 ± 0.19 0.61
6.01 ± 3.35 5.88 ± 3.55 0.56
21.56 ± 0.67 21.52 ± 0.67 0.97
Table 2
Change in best corrected visual acuity, intraocular pressure, number of medication,
and drainage angle parameters, between baseline (10 days after laser peripheral
iridotomy [LPI]) and final follow-up in the Phaco/LPI and LPI only groups.
Baseline Final follow-up p values
IOP (mmHg)
Phaco-LPI group 16.65 ± 2.75 13.90 ± 2.17 0.006
LPI only group 16.47 ± 2.71 17.80 ± 4.16 0.90
p values 0.88 0.001
Number of medication
Phaco-LPI group 1.10 ± 0.91 0.50 ± 2.20 0.001
LPI only group 0.93 ± 0.79 0.80 ± 1.08 0.71
p values 0.65 0.06
Shaffer gonioscopy grading
Phaco-LPI group 1.34 ± 0.47 2.88 ± 0.40 <0.001
LPI only group 1.36 ± 0.89 1.14 ± 0.92 0.69
p values 0.82 0.04
PAS (Degrees)
Phaco-LPI group 149.0 ± 128.1 66.0 ± 128.2 0.007
LPI only group 154.0 ± 118.0 178.1 ± 124.5 0.04
p values 0.87 0.02
BCVA (logMAR)
Phaco-LPI group 0.51 ± 0.28 0.29 ± 0.24 0.003
LPI only group 0.09 ± 0.08 0.10 ± 0.08 0.15
p values <0.001 <0.01
BCVA: best-corrected visual acuity; IOP: intraocular pressure; LPI: laser pe-
ripheral iridotomy; LogMAR: logarithm of minimum angle of resolution;
PAS: peripheral anterior synechiae.
Fig. 2. Line chart of intraocular pressure (IOP) over time. Although the IOP
was not significantly different between the two groups, Phaco/Laser peripheral
iridotomy (Phaco/LPI) group has significantly lower IOP than LPI Only group
during follow-up.
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There were no statistically significant differences in gender,
age, presenting IOP, time to presentation (from onset of
self-reported symptoms to clinical consultation), axial
length, gonioscopy grading, and vertical cup-to-disc ratio
between the two groups before LPI. Intraocular pressure,
number of medications, gonioscopy grading, and the
amount of PAS were not significantly different at baseline
(Table 2). However, the LPI Only group had better visual
acuity than the Phaco/LPI group. All the patients were
followed for at least 1 year. The mean follow-up period was
18.5 ± 5.2 months (range of 12e24 months).
Acute attack did not recur in any patient, as all iridotomies
remained patent. There was significantly more treatment
failure in the LPI Only group (6/15 [40%]) compared with the
Phaco/LPI group (1/20[5%]; p ¼ 0.02). All subjects classified
as treatment failure in this study were medically controlled at
the final follow-up and did not need any further intervention.
None of the patients with controlled IOP received the medi-
cation for VF progression. Four out of 6 failures in the LPI
Only group and the only failure in Phaco/LPI group developed
within the first 6 months of follow up.
Fig. 2 demonstrates the pattern of IOP change in both
groups during the follow-up period. There was a significant
difference in the final IOP between the two groups
(13.90 ± 2.17 vs. 17.8 ± 4.16 in Phaco/LPI and LPI Only
groups, respectively; p ¼ 0.001). Intraocular pressure was
significantly lower in the Phaco/LPI group throughout the
follow up period (all p < 0.005; Fig. 2). The Phaco/LPI group
patients needed fewer medications than did the other group at
the final follow-up for IOP control.The BCVA (logMAR) improved in the Phaco/LPI group
from 0.51 ± 0.28 at baseline to 0.29 ± 0.24 at the final follow-
up ( p ¼ 0.003). There was no significant change in BCVA in
the LPI Only group.
The change of average angle width and amount of PAS in
each group is shown in Table 2. There was a significant in-
crease in angle width from baseline to final follow up in the
Phaco/LPI group ( p < 0.001). Mean average gonioscopy did
not change in the LPI Only group throughout the follow-up
period. Baseline mean extent of synechial angle closure was
not different between two groups ( p ¼ 0.87), although more
PAS was observed in LPI Only group after 1 year ( p ¼ 0.02).
The amount of PAS decreased from 149.0 ± 128.1 to
66.0 ± 128.2 after phacoemulsification ( p ¼ 0.003). How-
ever, the LPI Only group experienced an increase in amount of
PAS during the follow-up period, from 149.0 ± 128.1 after
LPI to 178.1 ± 124.5 at the final visit; p ¼ 0.04).
Discussion
This study demonstrates the positive effects of early cata-
ract surgery on opening the angle, reducing PAS, and con-
trolling the IOP in patients with APAC. Forty percent of
patients who did not undergo phacoemulsification experienced
IOP rise subsequently.
LPI is an effective measure to prevent acute attack in APAC
eye and is believed to prevent progression to PACG in these
eyes. However, previous studies have produced conflicting
results and different rates of conversion to PACG. In Cauca-
sians, 65e76% of patients had long term medication-free
controlled IOP with surgical or laser iridectomy
alone.1,4,6,17,19,20 With use of glaucoma medications, this rate
increases to 84e99%.3
A report on Asian eyes revealed a 58.2% conversion rate to
PACG after LPI alone in APAC. Most of conversions to PACG
occurred during the first 6 months after LPI.3 Consistent with
these studies, our data revealed that after LPI 40% of patients
74 S. Moghimi et al. / Journal of Current Ophthalmology 27 (2015) 70e75need medications for adequate IOP control, and 60% of pa-
tients developed IOP rise in the first 6 months, indicating the
importance and need for strict follow-up after LPI, especially
during this early period. There is no study in the Iranian
population that reports the natural history of APAC after LPI.
However, in a recent study on PACG patients who underwent
LPI, Alipanahi et al showed that only 15% of eyes maintained
IOP control without medication after 21 months.21
The literature describing the effect of LPI on amount of
PAS is controversial. Although one study demonstrated a
decrease in PAS extent after LPI,17 several studies showed that
LPI has little effect on reversing established synechiae and but
may prevent progressive synechial closure after the proce-
dure.22 In our LPI Only group, the PAS extent increased
approximately 20 during the follow-up period. Over-
estimation of PAS extent before LPI in eyes with very shallow
anterior chambers in those studies and ethnic differences in
study populations may account for the discrepancy.
We observed that amount of PAS was significantly reduced
in the Phaco/LPI group. Mechanical deepening of the anterior
chamber during phacoemulsification may relieve PAS to some
extent.13 Some investigators reported beneficial effects of a
procedure called goniosynechiolysis, combined with phaco-
emulsification, to widen the anterior chamber angle, especially
in cases of APAC with recently formed PAS.16,23e25 This
observation has also been reported by Tham et al in Hong
Kong26 and Husain et al17 in Singapore in APAC eyes.
Desirable effects of lens extraction in glaucomatous and
nonglaucomatous eyes have been addressed recently in several
studies.11e15,27 Lens extraction has been shown to have greater
effect on IOP in eyes with refractory APAC and in eyes with
broken attacks.6,16e18 Moghimi et al found that eyes with
APAC have thicker lens and greater lens vault than do other
subtypes of angle closure.28e30 Phacoemulsification, by
removing the thick lens, can effectively open the drainage
angle and deepen the anterior chamber, as measured by ul-
trasound biomicroscopy.31
One randomized control study6 evaluated 62 eyes that
received either early phacoemulsification or LPI after breaking
the APAC attack by medication. After 18 months, prevalence of
IOP risewas significantly higher in the LPI group (46.7% versus
3.2%). The study proved phacoemulsification is superior to LPI
for long-term IOP control after an APAC attack. Consistent with
these studies, the rate of conversion to PAC was much lower in
our Phaco/LPI group (5%) than in the LPI Only group (40%).
We also observed lower IOP in the Phaco/LPI group at all
postoperative visits, and the Phaco/LPI group required fewer
medications at the final visit. This beneficial effect of phaco-
emulsification has been shown in another randomized control
trial,6 although there is some evidence in contrary.17
Phacoemulsification after acute attack of angle closure is a
challenging task. The surgery is technically challenging due to
a shallow anterior chamber, poor mydriasis, posterior syn-
echiae adherent to the lens, weakness of the zonular fibers, and
perhaps residual corneal edema after an acute attack. Optimal
timing of cataract extraction after an acute APAC attack
should not be early enough to avoid significant PAS formationand late enough to avoid complications of surgery in an
inflamed eye.6 Many investigators suggest the time point of
4e6 weeks after control of an acute attack to minimize these
risks.6 We reported no serious surgical complications after
phacoemulsification in our APAC cases. Previous studies
demonstrated that LPI reduces forward bowing of the iris due
to pupillary block in both APAC and PACG.32 Iris prolapse
during phacoemulsification is more common among patients
with iris convexity. All of our APAC eyes had LPI before
surgery, which may explain our low rate of complications such
as iris prolapse and postoperative inflammation secondary to
iris trauma.
Our study is unique in that it is the first study on effect of
phacoemulsification on APAC eyes after aboring the acute
attack in the Iranian population. However, potential limi-
tations may affect the generalizability of our findings. The
study population was small and may have limited power of
outcome comparisons. However, using post-hoc analysis,
our sample size (with type 1 error of 0.05) had a power of
81.2% to detect differences between two proportions of
40% in the LPI Only group and of 5% in the Phaco/LPI
group. Moreover, there was no randomization in dividing
patients. The LPI Only group comprised of patients who did
not have visually significant cataract, and the differences in
lens properties and thickness may have affected some
comparisons. Another limitation is that we documented PAS
by gonioscopy, which is a very subjective method. To
reduce the potential for error, a single clinician performed
all examinations. Finally, as this study was conducted in an
Iranian population, its results may not be generalizable to
other populations.
In summary, our study revealed that phacoemulsification is
a safe procedure for preventing IOP rise after aborting acute
primary angle closure if performed within a few weeks of the
attack. The rate of IOP rise is higher among those patients
treated by LPI only.References
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